Studies so time-intensive that they have thus far been impractical may soon enter the mainstream as a result of enhancements to GE Healthcare’s Excite data pipeline.
Studies so time-intensive that they have thus far been impractical may soon enter the mainstream as a result of enhancements to GE Healthcare's Excite data pipeline.
HD (high-definition) MR, the latest version of this technology, is being showcased at the ECR. It promises to have an immediate impact on difficult applications such as brain scans of children and patients with Parkinson's disease. HDMR has a similarly positive effect on motion-sensitive studies of the heart and abdomen, and it speeds up MR mammography by allowing data acquisition from both breasts simultaneously. It even supports dynamic MR angiography of the legs.
"We have designed a system that brings new clinical relevance to the medical community and, in the end, to the patients," said Stefano Vagliani, GE's general manger for MR in Europe. "We created new electronic devices, new interfaces, and clinical software that really brings additional value."
New high-performance surface coils acquire the data that HDMR processes. An example is a 32-element peripheral vascular coil that extends below the knee and covers each foot with what looks like a ski boot. The new coil, in combination with HDMR, allows dynamic imaging of blood flow.
The increased data flow from this and other such coils, along with the advanced processing capabilities of HDMR, enable the capture of MR data in novel ways. One method, called Propeller, acquires data radially rather than in the conventional rectilinear fashion. Propeller is relatively insensitive to motion and is therefore ideally suited for patients prone to movement. LAVA (liver acquisitions with volume acceleration) cuts scan time for liver and other abdominal applications. An acquisition process that mimics echocardiography allows cardiac imaging without ECGs. Other such methods are in the works.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.